首页> 外文期刊>European review for medical and pharmacological sciences. >Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study.
【24h】

Pattern analysis and variations in the utilization of antihypertensive drugs in Taiwan: a six-year study.

机译:台湾抗高血压药使用情况的模式分析和变化:一项为期六年的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

In the last few years there have been changed in the pattern of consumption of antihypertensive drugs in other countries. Factors causing this variability include differences in the effectiveness of detection, guidelines for the management of hypertension, and differences in national health insurance systems among countries.The aim of this study was to reveal patterns in the use of antihypertensive drugs in Taiwan over a six year period (2001 to 2006) and compare these results with data from other countries.This study performed descriptive analysis of data from the National Health Insurance Research Database (NHIRD) of Taiwan, and compared these findings with similar findings from around the world. Quantities were standardized using the defined daily dose (DDD) per 1000 inhabitants per day (DID) in accordance with WHO anatomical therapeutic classification and DDD measurement methodology.The total number of DDDs prescribed in Taiwan increased from 0.66 billion in 2001 to 1.08 billion in 2006, representing 80.6 and 129.2 DID in 2001 and 2006, respectively. This indicates a significant increase in the prescription of antihypertensive drugs in Taiwan over this period. The average annual increase ranged from 10.7% for calcium channel blockers (CCBs) to 22.1% for angiotensin II receptor blockers (ARBs). All of these patterns were statistically significant (p < 0.05). The rapid increase in the use of ARBs resulted in its surpassing ACEIs with the second highest DID (21.9) in 2006. Though the proportional use of CCBs and ARBs has increased significantly, the use of thiazide diuretics remains low.The consumption of antihypertension drugs in Taiwan increased during the period studied and the highest average annual increases were for ARBs and CCBs. Overall consumption of antihypertension drugs also increased in other countries, but differences in the relative increase for each class of drug suggest that further study may be required to clarify the origins and causes.
机译:在过去的几年中,其他国家的降压药消费方式发生了变化。导致这种差异的因素包括检测的有效性差异,高血压管理指南以及各国之间的国民健康保险制度差异。本研究旨在揭示台湾在过去六年中使用降压药的方式期间(2001年至2006年),并将这些结果与其他国家的数据进行比较。本研究对台湾国家健康保险研究数据库(NHIRD)的数据进行了描述性分析,并将这些发现与来自世界各地的类似发现进行了比较。根据世界卫生组织的解剖疗法分类和DDD测量方法,使用每千名居民每天定义的日剂量(DID)对数量进行标准化。台湾规定的DDD总数从2001年的6.6亿增加到2006年的10.8亿,分别代表2001年和2006年的DID为80.6和129.2。这表明在此期间,台湾的降压药处方大幅增加。钙通道阻滞剂(CCBs)的年平均增长率为10.7%,而血管紧张素II受体阻滞剂(ARBs)的年均增长率为22.1%。所有这些模式均具有统计学意义(p <0.05)。 ARB的使用迅速增加,导致其在2006年的DID(21.9)超过了ACEI,居第二位。尽管CCB和ARB的比例使用显着增加,但噻嗪类利尿剂的使用仍然很低。在所研究的时期内,台湾的增长量最大,而ARB和CCB的年均增长率最高。在其他国家,抗高血压药的总消费量也有所增加,但是每种药物相对增加的差异表明可能需要进一步研究以阐明其起源和原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号